We are live on
!
Find out more
NMC
Nine Masts Capital Portfolio holdings
AUM
$693M
1-Year Est. Return
31.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.21%
1 Year Est. Return
+31.93%
3 Year Est. Return
+76.49%
5 Year Est. Return
+38.28%
10 Year Est. Return
+77.77%
AUM
$693M
AUM Growth
+$112M
(+19%)
Cap. Flow
+$743M
Cap. Flow
% of AUM
107.21%
Top 10 Holdings %
Top 10 Hldgs %
63.05%
Holding
322
New
199
Increased
22
Reduced
15
Closed
73
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$75.1M |
| 2 |
HDFC Bank
HDB
|
+$59.1M |
| 3 |
Warner Bros
WBD
|
+$22.8M |
| 4 |
Silicon Laboratories
SLAB
|
+$21.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$20.1M |
Top Sells
| 1 |
iShares Bitcoin Trust
IBIT
|
+$93.8M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$68.3M |
| 3 |
Norfolk Southern
NSC
|
+$22.5M |
| 4 |
CYBR
CyberArk
CYBR
|
+$18.5M |
| 5 |
GSK
GSK
|
+$10.1M |
Sector Composition
| 1 | Communication Services | 22.79% |
| 2 | Financials | 11.24% |
| 3 | Technology | 9.72% |
| 4 | Healthcare | 4.95% |
| 5 | Industrials | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
System1
SST
$15.7M
| $56K | 0.01% |
+18,548
| New | +$62.4K |
|
127
P3 Health Partners
PIII
$37M
| $55.3K | 0.01% |
+17,964
| New | +$47.3K |
|
128
Galectin Therapeutics
GALT
$278M
| $53.9K | 0.01% |
+19,324
| New | +$58.8K |
|
129
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$14B
| $52.5K | 0.01% |
+420,000
| New | +$37.2M |
|
130
CALL
Verizon
VZ
$183B
| $51.4K | 0.01% |
+12,300
| New | +$570K |
|
|
ACH
131
Accendra Health
ACH
$289M
| $51K | 0.01% |
+22,373
| New | +$51.5K |
|
132
Pulmonx
LUNG
$61.2M
| $49.8K | 0.01% |
38,598
+28,492
| +282% | +$47.1K |
|
133
Biomea Fusion
BMEA
$91.1M
| $49.7K | 0.01% |
+32,472
| New | +$42.7K |
|
134
Future Fuel
FF
$203M
| $49.2K | 0.01% |
+12,782
| New | +$48K |
|
|
135
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$14B
| $48.8K | 0.01% |
+25,000
| New | +$2.21M |
|
136
Outlook Therapeutics
OTLK
$217M
| $47.9K | 0.01% |
+232,546
| New | +$100K |
|
137
ProQR Therapeutics
PRQR
$236M
| $47.8K | 0.01% |
+29,518
| New | +$48.4K |
|
138
Ironwood Pharmaceuticals
IRWD
$637M
| $47.5K | 0.01% |
+13,527
| New | +$55.4K |
|
139
CALL
Netflix
NFLX
$313B
| $47.1K | 0.01% |
+7,500
| New | +$661K |
|
140
Torrid Holdings
CURV
$222M
| $46.3K | 0.01% |
+26,011
| New | +$32.2K |
|
141
Lineage Cell Therapeutics
LCTX
$292M
| $46.1K | 0.01% |
+29,194
| New | +$49.2K |
|
142
W&T Offshore
WTI
$495M
| $45.9K | 0.01% |
13,453
+723
| +6% | +$1.79K |
|
|
FLNA
143
Filana Therapeutics
FLNA
$52.2M
| $45.8K | 0.01% |
+27,107
| New | +$55.8K |
|
144
Inovio Pharmaceuticals
INO
$92.1M
| $45.8K | 0.01% |
+26,317
| New | +$43.3K |
|
145
OmniAb
OABI
$296M
| $45.6K | 0.01% |
+29,062
| New | +$52.5K |
|
|
KLC
146
KinderCare Learning Companies
KLC
$619M
| $45.4K | 0.01% |
+20,626
| New | +$77.7K |
|
147
Invivyd
IVVD
$232M
| $45.1K | 0.01% |
+34,698
| New | +$63.7K |
|
148
Community Health Systems
CYH
$476M
| $45.1K | 0.01% |
+15,329
| New | +$49.7K |
|
149
Precigen
PGEN
$1.76B
| $44.9K | 0.01% |
+11,608
| New | +$47.6K |
|
150
MaxCyte
MXCT
$145M
| $44.7K | 0.01% |
+63,591
| New | +$59.4K |
|
Similar funds
HG
HA
M
HI
CGIC
CL
CPA
PM